nodes	percent_of_prediction	percent_of_DWPC	metapath
Cevimeline—CYP3A4—urine—bipolar disorder	0.0179	0.143	CbGeAlD
Cevimeline—CYP2D6—urine—bipolar disorder	0.0176	0.14	CbGeAlD
Cevimeline—FMO1—thyroid gland—bipolar disorder	0.0146	0.117	CbGeAlD
Cevimeline—FMO1—nervous system—bipolar disorder	0.0123	0.0981	CbGeAlD
Cevimeline—FMO1—brain—bipolar disorder	0.0094	0.075	CbGeAlD
Cevimeline—CYP3A4—blood plasma—bipolar disorder	0.00934	0.0745	CbGeAlD
Cevimeline—CYP2D6—blood plasma—bipolar disorder	0.00919	0.0733	CbGeAlD
Cevimeline—CHRM3—thyroid gland—bipolar disorder	0.00601	0.0479	CbGeAlD
Cevimeline—CHRM1—nervous system—bipolar disorder	0.00565	0.045	CbGeAlD
Cevimeline—CHRM3—nervous system—bipolar disorder	0.00505	0.0403	CbGeAlD
Cevimeline—CHRM1—brain—bipolar disorder	0.00432	0.0344	CbGeAlD
Cevimeline—CHRM3—brain—bipolar disorder	0.00386	0.0308	CbGeAlD
Cevimeline—CYP3A4—nervous system—bipolar disorder	0.00278	0.0221	CbGeAlD
Cevimeline—CYP2D6—nervous system—bipolar disorder	0.00273	0.0218	CbGeAlD
Cevimeline—CYP2D6—cerebellum—bipolar disorder	0.00257	0.0205	CbGeAlD
Cevimeline—CYP2D6—brain—bipolar disorder	0.00209	0.0167	CbGeAlD
Cevimeline—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD1—bipolar disorder	0.00161	0.00184	CbGpPWpGaD
Cevimeline—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2C—bipolar disorder	0.0016	0.00183	CbGpPWpGaD
Cevimeline—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD1—bipolar disorder	0.0016	0.00183	CbGpPWpGaD
Cevimeline—FMO1—Metabolism—ADCY2—bipolar disorder	0.00158	0.0018	CbGpPWpGaD
Cevimeline—CHRM1—GPCR ligand binding—ADM—bipolar disorder	0.00157	0.0018	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—ADM—bipolar disorder	0.00157	0.00179	CbGpPWpGaD
Cevimeline—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD3—bipolar disorder	0.00156	0.00178	CbGpPWpGaD
Cevimeline—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD3—bipolar disorder	0.00155	0.00178	CbGpPWpGaD
Cevimeline—CHRM1—GPCR ligand binding—TSHB—bipolar disorder	0.00153	0.00175	CbGpPWpGaD
Cevimeline—CHRM1—GPCR ligand binding—TACR1—bipolar disorder	0.00153	0.00175	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—TSHB—bipolar disorder	0.00153	0.00175	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—TACR1—bipolar disorder	0.00153	0.00175	CbGpPWpGaD
Cevimeline—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD4—bipolar disorder	0.00151	0.00173	CbGpPWpGaD
Cevimeline—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD4—bipolar disorder	0.00151	0.00172	CbGpPWpGaD
Cevimeline—CHRM1—G alpha (q) signalling events—HTR2A—bipolar disorder	0.00149	0.0017	CbGpPWpGaD
Cevimeline—CHRM3—G alpha (q) signalling events—HTR2A—bipolar disorder	0.00149	0.0017	CbGpPWpGaD
Cevimeline—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—bipolar disorder	0.00143	0.00164	CbGpPWpGaD
Cevimeline—CYP2D6—Phase 1 - Functionalization of compounds—POMC—bipolar disorder	0.00143	0.00163	CbGpPWpGaD
Cevimeline—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—bipolar disorder	0.00141	0.00161	CbGpPWpGaD
Cevimeline—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD2—bipolar disorder	0.0014	0.00161	CbGpPWpGaD
Cevimeline—FMO1—Metabolism—COMT—bipolar disorder	0.00135	0.00154	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—DGKH—bipolar disorder	0.00134	0.00154	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—DGKH—bipolar disorder	0.00134	0.00153	CbGpPWpGaD
Cevimeline—FMO1—Metabolism—MAOA—bipolar disorder	0.00134	0.00153	CbGpPWpGaD
Cevimeline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—bipolar disorder	0.00133	0.00152	CbGpPWpGaD
Cevimeline—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—bipolar disorder	0.00133	0.00152	CbGpPWpGaD
Cevimeline—CHRM1—GPCR ligand binding—HTR1A—bipolar disorder	0.00127	0.00145	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—HTR1A—bipolar disorder	0.00126	0.00145	CbGpPWpGaD
Cevimeline—CHRM1—GPCR ligand binding—TAC1—bipolar disorder	0.00125	0.00143	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—TAC1—bipolar disorder	0.00125	0.00142	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—DRD5—bipolar disorder	0.00123	0.00141	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—DRD5—bipolar disorder	0.00123	0.0014	CbGpPWpGaD
Cevimeline—CHRM1—GPCR ligand binding—HTR2C—bipolar disorder	0.00123	0.0014	CbGpPWpGaD
Cevimeline—CHRM1—GPCR ligand binding—DRD1—bipolar disorder	0.00123	0.0014	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—DRD1—bipolar disorder	0.00122	0.0014	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—HTR2C—bipolar disorder	0.00122	0.0014	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—DGKH—bipolar disorder	0.00122	0.0014	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—DGKH—bipolar disorder	0.00122	0.00139	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—RGS4—bipolar disorder	0.00121	0.00138	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—RGS4—bipolar disorder	0.0012	0.00137	CbGpPWpGaD
Cevimeline—CHRM1—GPCR ligand binding—DRD3—bipolar disorder	0.00119	0.00136	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—DRD3—bipolar disorder	0.00118	0.00135	CbGpPWpGaD
Cevimeline—CYP2D6—Biological oxidations—COMT—bipolar disorder	0.00117	0.00134	CbGpPWpGaD
Cevimeline—CYP2D6—Biological oxidations—MAOA—bipolar disorder	0.00117	0.00133	CbGpPWpGaD
Cevimeline—CYP2D6—Metapathway biotransformation—COMT—bipolar disorder	0.00116	0.00132	CbGpPWpGaD
Cevimeline—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—bipolar disorder	0.00115	0.00132	CbGpPWpGaD
Cevimeline—CHRM1—GPCR ligand binding—DRD4—bipolar disorder	0.00115	0.00132	CbGpPWpGaD
Cevimeline—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—bipolar disorder	0.00115	0.00132	CbGpPWpGaD
Cevimeline—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—bipolar disorder	0.00115	0.00131	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—DRD4—bipolar disorder	0.00115	0.00131	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—IMPA1—bipolar disorder	0.00113	0.0013	CbGpPWpGaD
Cevimeline—CHRM1—Circadian rythm related genes—GSK3B—bipolar disorder	0.00113	0.0013	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—DRD5—bipolar disorder	0.00112	0.00128	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—DRD5—bipolar disorder	0.00111	0.00127	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—RGS4—bipolar disorder	0.00109	0.00125	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—RGS4—bipolar disorder	0.00109	0.00125	CbGpPWpGaD
Cevimeline—FMO1—Metabolism—MTHFR—bipolar disorder	0.00109	0.00125	CbGpPWpGaD
Cevimeline—CHRM1—GPCR ligand binding—DRD2—bipolar disorder	0.00107	0.00123	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—DRD2—bipolar disorder	0.00107	0.00122	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—IMPA2—bipolar disorder	0.001	0.00115	CbGpPWpGaD
Cevimeline—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—bipolar disorder	0.000987	0.00113	CbGpPWpGaD
Cevimeline—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—bipolar disorder	0.000984	0.00113	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—NDUFV2—bipolar disorder	0.000965	0.0011	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—AKR1C4—bipolar disorder	0.000934	0.00107	CbGpPWpGaD
Cevimeline—CYP3A4—Phase 1 - Functionalization of compounds—POMC—bipolar disorder	0.000934	0.00107	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—TRPC3—bipolar disorder	0.000932	0.00107	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—TRPC3—bipolar disorder	0.000929	0.00106	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—ADM—bipolar disorder	0.000889	0.00102	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—ADM—bipolar disorder	0.000886	0.00101	CbGpPWpGaD
Cevimeline—FMO1—Metabolism—POMC—bipolar disorder	0.000872	0.000997	CbGpPWpGaD
Cevimeline—FMO1—Metabolism—INS—bipolar disorder	0.000867	0.000992	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—TSHB—bipolar disorder	0.000866	0.00099	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—PDE4B—bipolar disorder	0.000866	0.00099	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—TACR1—bipolar disorder	0.000866	0.00099	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—TSHB—bipolar disorder	0.000864	0.000987	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—PDE4B—bipolar disorder	0.000864	0.000987	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—TACR1—bipolar disorder	0.000864	0.000987	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—TRPC3—bipolar disorder	0.000846	0.000967	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—TRPC3—bipolar disorder	0.000843	0.000964	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—NR1D1—bipolar disorder	0.000839	0.000959	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—ADM—bipolar disorder	0.000807	0.000923	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—ADM—bipolar disorder	0.000805	0.00092	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—NCAN—bipolar disorder	0.000803	0.000918	CbGpPWpGaD
Cevimeline—CHRM1—Class A/1 (Rhodopsin-like receptors)—POMC—bipolar disorder	0.000788	0.000901	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—TACR1—bipolar disorder	0.000787	0.000899	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—TSHB—bipolar disorder	0.000787	0.000899	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—PDE4B—bipolar disorder	0.000787	0.000899	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—SLC5A3—bipolar disorder	0.000786	0.000899	CbGpPWpGaD
Cevimeline—CHRM3—Class A/1 (Rhodopsin-like receptors)—POMC—bipolar disorder	0.000786	0.000899	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—TSHB—bipolar disorder	0.000784	0.000897	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—TACR1—bipolar disorder	0.000784	0.000897	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—PDE4B—bipolar disorder	0.000784	0.000897	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—AKR1C4—bipolar disorder	0.000784	0.000896	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—AKR1C4—bipolar disorder	0.000781	0.000893	CbGpPWpGaD
Cevimeline—CYP3A4—Biological oxidations—COMT—bipolar disorder	0.000767	0.000877	CbGpPWpGaD
Cevimeline—CYP3A4—Biological oxidations—MAOA—bipolar disorder	0.000762	0.000871	CbGpPWpGaD
Cevimeline—CYP2D6—Biological oxidations—POMC—bipolar disorder	0.000759	0.000867	CbGpPWpGaD
Cevimeline—CYP3A4—Metapathway biotransformation—COMT—bipolar disorder	0.000757	0.000865	CbGpPWpGaD
Cevimeline—CHRM1—GPCR ligand binding—HTR2A—bipolar disorder	0.000752	0.00086	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—HTR2A—bipolar disorder	0.000749	0.000857	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—DGKH—bipolar disorder	0.000721	0.000825	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—DGKH—bipolar disorder	0.000719	0.000822	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—HTR1A—bipolar disorder	0.000717	0.00082	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—HTR1A—bipolar disorder	0.000715	0.000817	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—TAC1—bipolar disorder	0.000706	0.000807	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—TAC1—bipolar disorder	0.000704	0.000805	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—HTR2C—bipolar disorder	0.000693	0.000792	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—DRD1—bipolar disorder	0.000693	0.000792	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—DRD1—bipolar disorder	0.00069	0.000789	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—HTR2C—bipolar disorder	0.00069	0.000789	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—IMPA1—bipolar disorder	0.000678	0.000776	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—DRD3—bipolar disorder	0.000671	0.000767	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—DRD3—bipolar disorder	0.000669	0.000764	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—DRD5—bipolar disorder	0.00066	0.000754	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—DRD5—bipolar disorder	0.000657	0.000752	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—IMPA2—bipolar disorder	0.000657	0.000751	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—HTR1A—bipolar disorder	0.000651	0.000745	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—DRD4—bipolar disorder	0.000651	0.000744	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—HTR1A—bipolar disorder	0.000649	0.000742	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—DRD4—bipolar disorder	0.000649	0.000742	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—RGS4—bipolar disorder	0.000647	0.00074	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—RGS4—bipolar disorder	0.000645	0.000737	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—TAC1—bipolar disorder	0.000641	0.000733	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—TAC1—bipolar disorder	0.000639	0.000731	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—HTR2C—bipolar disorder	0.000629	0.000719	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—DRD1—bipolar disorder	0.000629	0.000719	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—DRD1—bipolar disorder	0.000627	0.000717	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—HTR2C—bipolar disorder	0.000627	0.000717	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—ADCY2—bipolar disorder	0.000613	0.000701	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—ADCY2—bipolar disorder	0.000611	0.000699	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—DRD3—bipolar disorder	0.000609	0.000696	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—DRD3—bipolar disorder	0.000607	0.000694	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—DRD2—bipolar disorder	0.000607	0.000694	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—DRD2—bipolar disorder	0.000605	0.000691	CbGpPWpGaD
Cevimeline—CHRM1—GPCR ligand binding—POMC—bipolar disorder	0.0006	0.000686	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—POMC—bipolar disorder	0.000598	0.000684	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—DRD4—bipolar disorder	0.000591	0.000676	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—DRD4—bipolar disorder	0.000589	0.000674	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—NDUFV2—bipolar disorder	0.000577	0.000659	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—CLOCK—bipolar disorder	0.000568	0.00065	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—AKR1C4—bipolar disorder	0.000559	0.000639	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—ADCY2—bipolar disorder	0.000557	0.000636	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—ADCY2—bipolar disorder	0.000555	0.000634	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—TSHB—bipolar disorder	0.000554	0.000633	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—CACNB2—bipolar disorder	0.000554	0.000633	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—TPH2—bipolar disorder	0.000554	0.000633	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—DRD2—bipolar disorder	0.000551	0.00063	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—DRD2—bipolar disorder	0.000549	0.000628	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—DPYD—bipolar disorder	0.000545	0.000623	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—CACNA1C—bipolar disorder	0.000507	0.000579	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—NR1D1—bipolar disorder	0.000502	0.000574	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—TRPC3—bipolar disorder	0.0005	0.000572	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—TRPC3—bipolar disorder	0.000498	0.00057	CbGpPWpGaD
Cevimeline—CYP3A4—Biological oxidations—POMC—bipolar disorder	0.000496	0.000567	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—PIK3C2A—bipolar disorder	0.000494	0.000565	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—NCAN—bipolar disorder	0.00048	0.000549	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—ADM—bipolar disorder	0.000477	0.000545	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—ADM—bipolar disorder	0.000475	0.000543	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—SLC5A3—bipolar disorder	0.00047	0.000538	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—PDE4B—bipolar disorder	0.000465	0.000531	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—TACR1—bipolar disorder	0.000465	0.000531	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—TSHB—bipolar disorder	0.000465	0.000531	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—TSHB—bipolar disorder	0.000463	0.00053	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—PDE4B—bipolar disorder	0.000463	0.00053	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—TACR1—bipolar disorder	0.000463	0.00053	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—IMPA1—bipolar disorder	0.000443	0.000507	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—SNAP25—bipolar disorder	0.000443	0.000506	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—HTR2A—bipolar disorder	0.000425	0.000486	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—HTR2A—bipolar disorder	0.000423	0.000484	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—ADCY2—bipolar disorder	0.000392	0.000448	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—HTR2A—bipolar disorder	0.000386	0.000441	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—HTR1A—bipolar disorder	0.000385	0.00044	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—HTR2A—bipolar disorder	0.000385	0.00044	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—HTR1A—bipolar disorder	0.000383	0.000438	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—TAC1—bipolar disorder	0.000379	0.000433	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—TAC1—bipolar disorder	0.000378	0.000432	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—NDUFV2—bipolar disorder	0.000377	0.000431	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—DRD1—bipolar disorder	0.000372	0.000425	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—HTR2C—bipolar disorder	0.000372	0.000425	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—HTR2C—bipolar disorder	0.00037	0.000423	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—DRD1—bipolar disorder	0.00037	0.000423	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—AKR1C4—bipolar disorder	0.000365	0.000418	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—NTRK2—bipolar disorder	0.000361	0.000413	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—NTRK2—bipolar disorder	0.00036	0.000412	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—DRD3—bipolar disorder	0.00036	0.000411	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—DRD3—bipolar disorder	0.000359	0.00041	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—GSK3A—bipolar disorder	0.000358	0.00041	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—GSK3A—bipolar disorder	0.000357	0.000408	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—DRD4—bipolar disorder	0.000349	0.000399	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—DRD4—bipolar disorder	0.000348	0.000398	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—CLOCK—bipolar disorder	0.00034	0.000389	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—POMC—bipolar disorder	0.000339	0.000388	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—POMC—bipolar disorder	0.000338	0.000387	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—COMT—bipolar disorder	0.000336	0.000384	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—MAOA—bipolar disorder	0.000333	0.000381	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—TPH2—bipolar disorder	0.000331	0.000379	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—TSHB—bipolar disorder	0.000331	0.000379	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—CACNB2—bipolar disorder	0.000331	0.000379	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—ADCY2—bipolar disorder	0.000329	0.000376	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—NR1D1—bipolar disorder	0.000328	0.000375	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—ADCY2—bipolar disorder	0.000328	0.000375	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—TCF7L2—bipolar disorder	0.000328	0.000375	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—TCF7L2—bipolar disorder	0.000327	0.000373	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—DPYD—bipolar disorder	0.000326	0.000373	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—DRD2—bipolar disorder	0.000325	0.000372	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—DRD2—bipolar disorder	0.000324	0.000371	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—NCAN—bipolar disorder	0.000314	0.000359	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—POMC—bipolar disorder	0.000308	0.000352	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—SLC5A3—bipolar disorder	0.000307	0.000351	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—POMC—bipolar disorder	0.000307	0.000351	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—CACNA1C—bipolar disorder	0.000303	0.000346	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—PIK3C2A—bipolar disorder	0.000295	0.000338	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—NTRK1—bipolar disorder	0.000295	0.000337	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—NTRK1—bipolar disorder	0.000294	0.000336	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—S100B—bipolar disorder	0.000286	0.000327	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—S100B—bipolar disorder	0.000285	0.000326	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—MTHFR—bipolar disorder	0.000271	0.00031	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—SNAP25—bipolar disorder	0.000265	0.000303	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—NRG1—bipolar disorder	0.000253	0.000289	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—NRG1—bipolar disorder	0.000252	0.000288	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—ADCY2—bipolar disorder	0.000234	0.000268	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—HTR2A—bipolar disorder	0.000228	0.000261	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—HTR2A—bipolar disorder	0.000227	0.00026	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—CLOCK—bipolar disorder	0.000222	0.000254	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—POMC—bipolar disorder	0.000217	0.000248	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—TSHB—bipolar disorder	0.000217	0.000248	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—CACNB2—bipolar disorder	0.000217	0.000248	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—TPH2—bipolar disorder	0.000217	0.000248	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—INS—bipolar disorder	0.000216	0.000247	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—DPYD—bipolar disorder	0.000213	0.000244	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—COMT—bipolar disorder	0.000201	0.000229	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—MAOA—bipolar disorder	0.000199	0.000228	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—CACNA1C—bipolar disorder	0.000198	0.000226	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PIK3C2A—bipolar disorder	0.000193	0.000221	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—GSK3B—bipolar disorder	0.000183	0.00021	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—GSK3B—bipolar disorder	0.000183	0.000209	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—POMC—bipolar disorder	0.000182	0.000208	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—POMC—bipolar disorder	0.000181	0.000207	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—INS—bipolar disorder	0.000181	0.000207	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—INS—bipolar disorder	0.00018	0.000206	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—SNAP25—bipolar disorder	0.000173	0.000198	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—MTHFR—bipolar disorder	0.000162	0.000185	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—ADCY2—bipolar disorder	0.000153	0.000175	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—COMT—bipolar disorder	0.000131	0.00015	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—MAOA—bipolar disorder	0.00013	0.000149	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—POMC—bipolar disorder	0.00013	0.000148	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—INS—bipolar disorder	0.000129	0.000148	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—MTHFR—bipolar disorder	0.000106	0.000121	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—POMC—bipolar disorder	8.48e-05	9.7e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—INS—bipolar disorder	8.44e-05	9.64e-05	CbGpPWpGaD
